Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
141.6 USD | -1.02% | +2.77% | +7.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.45% | 14.39B | |
-1.47% | 104B | |
+7.16% | 97.47B | |
+5.71% | 22.25B | |
-12.57% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.97% | 16.36B | |
+38.15% | 12.37B | |
+308.06% | 8.43B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Citigroup Adjusts Price Target on Neurocrine Biosciences to $129 From $127, Maintains Buy Rating